Jazz lifted by third EU approval for GW Pharma's Epidyolex

GW Pharmaceuticals' Epidyolex has been approved in the EU for a third epilepsy indication, giving a boost for the company ahead of its $7.2 billion

UCB backs epilepsy-focused digital heath startup Nile AI

Belgian drugmaker UCB has been steadily building its digital health expertise<

Israel's NeuroHelp to trial AI device that predicts epilepti...

NeuroHelp, a spin-off from Israel’s Ben-Gurion University of the Negev, has developed what it claims to be the first wearable artificial intelligence (AI) device that detects and predicts e

Searching for answers in rare epilepsy

Geneticist Dr Charles Steward has spent his career studying the human genome – but his work became much more personal when his children were diagnosed with severe neurological diseases.

Sanofi faces possible manslaughter charges in epilepsy drug ...

Sanofi has been placed under formal investigation in France for possible charges including manslaughter relating to the epilepsy drug Depakine, following the deaths of four babies whose mot

Failed trial puts future of UCB’s epilepsy drug padsevonil i...